14.14

14.14 (0.02%)

As of Mar 01, 2024

KalVista Pharmaceuticals, Inc. [KALV]

Source: 

Company Overview

We are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. We apply our insights into the chemistry and biology of proteases to develop orally delivered, small molecule inhibitors with high selectivity, potency and bioavailability that we believe will make them successful treatments for diseases.

CountryUS
Headquarterscambridgemassachusetts
Phone Number(857) 999-0075
Industrypharmaceutical preparations
CEOT. Andrew Crockett
Websitewww.kalvista.com

Recent Stories